gemcitabine-erlotinib regimen
(jem-SY-tuh-been-er-LOH-tih-nib REH-jih-men)
A chemotherapy combination used for the treatment of locally advanced and metastatic pancreatic cancer. It includes the drugs gemcitabine hydrochloride and erlotinib hydrochloride. Also called gemcitabine-Tarceva regimen.